COSMO BIO COMPANY,LIMITED FY2025 Q3 Earnings Report | IR Tracker

COSMO BIO COMPANY,LIMITED FY2025 Q3 Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥7.88B
Operating Income: ¥275M
Net Income: ¥277M
EPS: ¥47.96

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥7.88B	¥7.41B	+6.4%
Cost of Sales	¥5.15B	¥4.94B	+4.3%
Gross Profit	¥2.74B	¥2.47B	+10.7%
SG&A Expenses	¥2.46B	¥2.10B	+17.1%
Operating Income	¥275M	¥369M	-25.5%
Non-operating Income	¥103M	¥54M	+90.7%
Non-operating Expenses	¥9M	¥38M	-76.3%
Ordinary Income	¥369M	¥384M	-3.9%
Profit Before Tax	¥397M	¥438M	-9.4%
Income Tax Expense	¥119M	¥136M	-12.5%
Net Income	¥277M	¥301M	-8.0%
Net Income Attributable to Owners	¥272M	¥291M	-6.5%
Total Comprehensive Income	¥723M	¥666M	+8.6%
Interest Expense	¥0	¥0	-
Basic EPS	¥47.96	¥49.92	-3.9%
Dividend Per Share	¥14.00	¥14.00	+0.0%

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥7.16B	¥7.23B	¥-72M
Cash and Deposits	¥2.99B	¥2.39B	+¥600M
Accounts Receivable	¥2.67B	¥2.96B	¥-286M
Inventories	¥951M	¥989M	¥-38M
Non-current Assets	¥5.11B	¥4.49B	+¥616M

Profitability Ratios

Item	Value
Net Profit Margin	3.4%
Gross Profit Margin	34.7%
Current Ratio	646.5%
Quick Ratio	560.6%
Debt-to-Equity Ratio	0.24x
Effective Tax Rate	30.0%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	+6.4%
Operating Income YoY Change	-25.4%
Ordinary Income YoY Change	-3.9%
Net Income Attributable to Owners YoY Change	-6.3%
Total Comprehensive Income YoY Change	+8.6%

Item	Value
Shares Outstanding (incl. Treasury)	6.05M shares
Treasury Stock	373K shares
Average Shares Outstanding	5.69M shares
Book Value Per Share	¥1,739.02

Dividend Information

Item	Amount
Q2 Dividend	¥14.00
Year-End Dividend	¥36.00

Full Year Forecast

Item	Forecast
Net Sales Forecast	¥10.70B
Operating Income Forecast	¥490M
Ordinary Income Forecast	¥580M
Net Income Attributable to Owners Forecast	¥430M
Basic EPS Forecast	¥75.77
Dividend Per Share Forecast	¥25.00